background preloader

OSINT in practice

Facebook Twitter

Presentations. OSINT and the Pharmaceutical Enterprise - Part 3. By James Golden Feb. 1, 2008 | Part 2 of this article appeared in the previous issue of Bio-IT World.

OSINT and the Pharmaceutical Enterprise - Part 3

In my previous two columns, I discussed the application of Open Source Intelligence (OSINT) to improving pharmaceutical IT and business analysis, and outlined some tools and techniques for building a pharmaceutical intelligence capability. In the final column in this series, I discuss how to make intelligence actionable, with a real example.

Useful intelligence needs to be actionable. What’s the point of searching for something if you don’t do anything with it? Once you create a repeatable system for answering your own or management’s questions, you may be asked to create all manner of regular reports. . • Indications and Warnings identifying potential actions with the goal of providing sufficient warning to preempt or counter their outcome (a bad press release, a competitor’s announcement, the cancelation of a clinical trial, a warning letter from the FDA, etc.). OSINT and the Pharmaceutical Enterprise - Part 2. Dec. 17, 2007 | Many OSINT (Open Source Intelligence) resources are available online, but the real art to OSINT analysis is in framing the right questions and creating the right sort of analysis for decision makers.

OSINT and the Pharmaceutical Enterprise - Part 2

While many free and commercial search engines and content aggregators exist in the public domain, a tailored retrieval, discovery, and refinement process must be created for answering specific intelligence questions around biopharma portfolios and practices from open sources. Many readers will have ample experience using (if not developing) such tools - whether building a corporate-wide search strategy, modeling data as taxonomies or ontologies, or building semantic-web applications.

Many vendors supply these tools, often quite cutting-edge. However, a more complete approach to intelligence collection and analysis requires focusing on system integration and the final intelligence product, rather than the newest, coolest piece of technology. Jim Golden is a CTO at SAIC. OSINT and the Pharmaceutical Enterprise.

Nov. 13, 2007 | In its July 2004 report, the 9/11 Commission recommended the creation of an “open-source” intelligence agency — somewhat different than the CIA and NSA.

OSINT and the Pharmaceutical Enterprise

Open Source Intelligence (OSINT) is defined by the Director of National Intelligence as intelligence “produced from publicly available information that is collected, exploited, and disseminated in a timely manner to an appropriate audience for the purpose of addressing a specific intelligence requirement.” OSINT focuses on creating actionable intelligence from public information, allowing other Federal agencies to focus on creating primary intelligence from covert human sources or listening in on electronic communications. Many OSINT resources are available via the millions of Web pages, blogs and databases on the World Wide Web.

Obviously, information technology is essential to the pharmaceutical enterprise. However, technology is only one piece of the puzzle. Question asking (and answering) is a fine art. Terrorism Open Source Intelligence Report (TOSIR) No. 339 10 July 2008. Skip to comments.

Terrorism Open Source Intelligence Report (TOSIR) No. 339 10 July 2008

Terrorism Open Source Intelligence Report (TOSIR) No. 339 10 July 2008 Terrorism Open Source Intelligence Report (TOSIR) #339 ^ | July 10, 2008 | Interaction Systems Incorporated Posted on Mon 14 Jul 2008 03:48:41 PM CEST by SMARTY Contents Article 1 “Seven Questions: Twilight of the Arab Moderates,” an Interview of Marwan Muasher, Foreign Policy, Web Exclusive, June 2008. Marwan Muasher was at the forefront of efforts to bring peace to the Middle East in the 1990s. Article 2 “Foe, Not Friend,” by Frank Gaffney, CSP Decision Brief (Center for Security Policy), 16 June 2008.

Article 3 “Al-Qaeda Warrior Uses Internet to Rally Women,” by Elaine Sciolino and Souad Mekhennet, New York Times, 28 May 2008. Article 4 “DHS Notifies Chemical Facilities They Are in High-Risk Category,” by Rob Margetta, CQ Homeland Security (Congressional Quarterly), 22 June 2008. Article 5 “Review: U.S. Top of TOSIR Cover Page Articles Article 1 Return to TOSIR Cover Page. Repository.jeffmalone.org/files/personal/OSI Paper.pdf. Www.icicompanies.com/DIB OS 2009-5-4.pdf. Www.cops.usdoj.gov/pdf/e09042536_Chapter_02.pdf.

Tr/fulltext/u2/a497362.